These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Rifampicin and isoniazid in the intermittent treatment of experimental tuberculosis in guinea-pigs]. Daddi G; Lucchesi M; Mancini P Ann Ist Carlo Forlanini; 1969; 29(1):35-40. PubMed ID: 5405839 [No Abstract] [Full Text] [Related]
11. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)]. Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898 [TBL] [Abstract][Full Text] [Related]
12. [Research on the protective action of rifampicin administered intermittently in experimental tuberculosis in guinea pigs]. Algeorge G; Sibilla S; Rudesco D Ann Pediatr (Paris); 1970 Oct; 17(10):674. PubMed ID: 5475418 [No Abstract] [Full Text] [Related]
13. Role of individual drugs in the chemotherapy of tuberculosis. Mitchison DA Int J Tuberc Lung Dis; 2000 Sep; 4(9):796-806. PubMed ID: 10985648 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics of rifampicin in experimental animals and in man]. Curci G; Ninni A Lotta Tuberc; 1971; 41(3):354-66. PubMed ID: 5291093 [No Abstract] [Full Text] [Related]
16. Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection. Yu WC; Lai ST; Chiu MC; Chau TN; Ng TK; Tam CM Int J Tuberc Lung Dis; 2006 Jul; 10(7):824-5. PubMed ID: 16850548 [No Abstract] [Full Text] [Related]
17. Intracellular growth and drug susceptibility of Mycobacterium tuberculosis in macrophages. Chanwong S; Maneekarn N; Makonkawkeyoon L; Makonkawkeyoon S Tuberculosis (Edinb); 2007 Mar; 87(2):130-3. PubMed ID: 16860611 [TBL] [Abstract][Full Text] [Related]
18. Synergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs in vitro. Chen P; Gearhart J; Protopopova M; Einck L; Nacy CA J Antimicrob Chemother; 2006 Aug; 58(2):332-7. PubMed ID: 16751637 [TBL] [Abstract][Full Text] [Related]
19. Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998. Remis RS; Jamieson F; Chedore P; Haddad A; Vernich L Clin Infect Dis; 2000 Aug; 31(2):427-32. PubMed ID: 10987700 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients. Dhingra VK; Rajpal S; Bhalla P; Yadav A; Jain SK; Hanif M J Commun Dis; 2003 Jun; 35(2):82-9. PubMed ID: 15562953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]